AU2003282629A1 - Use of domperidone for reducing fertility in mammalian females - Google Patents

Use of domperidone for reducing fertility in mammalian females

Info

Publication number
AU2003282629A1
AU2003282629A1 AU2003282629A AU2003282629A AU2003282629A1 AU 2003282629 A1 AU2003282629 A1 AU 2003282629A1 AU 2003282629 A AU2003282629 A AU 2003282629A AU 2003282629 A AU2003282629 A AU 2003282629A AU 2003282629 A1 AU2003282629 A1 AU 2003282629A1
Authority
AU
Australia
Prior art keywords
domperidone
mammalian females
reducing fertility
fertility
reducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003282629A
Other versions
AU2003282629A8 (en
Inventor
Herman Jan Tijmen Coelingh-Bennink
Rene Frank Van Der Linden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pantarhei Bioscience BV
Original Assignee
Pantarhei Bioscience BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pantarhei Bioscience BV filed Critical Pantarhei Bioscience BV
Publication of AU2003282629A1 publication Critical patent/AU2003282629A1/en
Publication of AU2003282629A8 publication Critical patent/AU2003282629A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
AU2003282629A 2002-11-20 2003-11-20 Use of domperidone for reducing fertility in mammalian females Abandoned AU2003282629A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02079846.8 2002-11-20
EP02079846 2002-11-20
PCT/NL2003/000817 WO2004045613A2 (en) 2002-11-20 2003-11-20 Use of domperidone for reducing fertility in mammalian females

Publications (2)

Publication Number Publication Date
AU2003282629A1 true AU2003282629A1 (en) 2004-06-15
AU2003282629A8 AU2003282629A8 (en) 2004-06-15

Family

ID=32319636

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003282629A Abandoned AU2003282629A1 (en) 2002-11-20 2003-11-20 Use of domperidone for reducing fertility in mammalian females

Country Status (2)

Country Link
AU (1) AU2003282629A1 (en)
WO (1) WO2004045613A2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6224895B1 (en) * 1996-12-18 2001-05-01 Clemson University Method for promoting ovulation, parturition, and lactation in mammals

Also Published As

Publication number Publication date
WO2004045613A3 (en) 2004-08-12
WO2004045613A2 (en) 2004-06-03
AU2003282629A8 (en) 2004-06-15

Similar Documents

Publication Publication Date Title
AU2003298514A1 (en) Methods and compositions using cholinesterase inhibitors
AU2003259735A1 (en) Small-mer compositions and methods of use
AU2003252305A1 (en) Composition for preparation for external use on skin and method of using the same
AU2001249969A1 (en) Inha inhibitors and their use as antibacterials
AU2003298712A1 (en) Methods and compositions for applying pharmacologic agents to the ear
AU2003261449A1 (en) Compositions for rna interference and methods of use thereof
AU2003270605A1 (en) Compositions for thermal insulation and methods of using the same
EP2283724B8 (en) Heterospermic insemination to assess sperm function
AU2003220361A1 (en) Benzamides and compositions benzamides for use as fungizide
AU2003214226A1 (en) Topical formulations of resorcinols and cannibinoids and methods of use
AU2003211005A1 (en) Compositions comprising reproductive cell media and methods for using such compositions
AU2003299441A1 (en) Nf-hev compositions and methods of use
AU2001238363A1 (en) Compositions for preventing cellulite in mammalian skin
AU2003232848A1 (en) Phenylaminopyrimidines and their use as rho-kinase inhibitors
AU2003272719A1 (en) Inhibitors of the nitrix oxide synthase iii (nos iii) as neuroprotective agents
AU2003216840A1 (en) Transdifferentiation of cells and tissues
AU2002256304A1 (en) Compositions for delivery of compounds to cells and methods of use
AU2003290722A1 (en) Methods and compositions for detecting telomerase activity
AU2003216367A1 (en) Biglycan and related therapeutics and methods of use
HK1060872A1 (en) High k glass and tape composition for use at high frequency
AU2003239901A1 (en) Crisp polypeptides as contraceptives and inhibitors of sperm capacitation
GB0218798D0 (en) Improvements to determination of ovulation
AU2003215264A1 (en) Compositions and methods for delivery of skin cosmeceuticals
AU2003282629A1 (en) Use of domperidone for reducing fertility in mammalian females
AU2003209634A1 (en) Galectin-8and functional derivatives as binding agents for cd44 glycoproteins and methods of use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase